Topic: Modeling And Simulation
A new, promising data source that could help explore and unlock new discoveries lies in the use of simulated data that can be used in place of real patient information.
Certara said its software supported 95% of the 20 novel FDA approvals from the first half of this year, as the agency aims to modernize its reviews.
Analytica Laser has a novel system which the company touts as the industry's first dynamic tool to predict real-world health outcomes.
The StealthStation ENT device uses electromagnetic tracking technology to show surgeons the locations of their instruments during procedures.
Private equity firm EQT is acquiring Certara from Arsenal Capital Partners, a deal that values the CRO at $850 million, Arsenal announced on Tuesday.
Nostrum has spun out of a pair of Spanish research institutions with ambitions to use supercomputer-powered computational simulations to improve drug discovery.
Bionext has picked up Rhenovia Pharma's cell signaling modeling technology and the R&D team that developed it to form a subsidiary, TheraScape.